Skip to main content

The Removal of Endocrine Disrupting Compounds and Pharmaceuticals from Membrane Bioreactor Effluent by Membrane Filtration

Buy Article:

$17.50 plus tax (Refund Policy)

Or sign up for a free trial

Abstract:

This study examined the rejection of twenty-two endocrine disrupting compounds (EDCs) and pharmaceutically active compounds (PhAC) from membrane bioreactor effluent and laboratory-grade water (Milli-Q®) by ‘loose’ and ‘tight’ nanofiltration (NF) membranes as well as a reverse osmosis (RO) membrane. Rejection by the ‘tight’ NF membrane was found to be most strongly correlated with individual compound log Kow values and water solubility, with the more hydrophobic compounds showing higher rejection. The RO membrane provided efficient EDC and PhAC removal (>90%). Conversely, in general, the ‘loose’ NF membrane offered poor and variable compound removal. Fouling and the presence of organic matter likely contributed to higher rejections of EDCs and PhACs by the membranes.

Document Type: Research Article

DOI: https://doi.org/10.2175/193864708788803929

Publication date: 2008-01-01

More about this publication?
  • Proceedings of the Water Environment Federation is an archive of papers published in the proceedings of the annual Water Environment Federation® Technical Exhibition and Conference (WEFTEC® ) and specialty conferences held since the year 2000. These proceedings are not peer reviewed.

    WEF Members: Sign in (right panel) with your IngentaConnect user name and password to receive complimentary access.
  • Subscribe to this Title
  • Membership Information
  • About WEF Proceedings
  • WEFTEC Conference Information
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more